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Abstract
An elevated temperature has many aetiologies, both
infective and non-infective, and while the fever of sepsis
probably confers benefit, there is increasing evidence
that the central nervous system is particularly vulnerable
to damage from hyperthermia. A single episode of
hyperthermia may cause short-term neurological and
cognitive dysfunction, which may be prolonged or
become permanent. The cerebellum is particularly
intolerant to the effects of heat. Hyperthermia in the
presence of acute brain injury worsens outcome. The
thermotoxicity involved occurs via cellular, local, and
systemic mechanisms. This article reviews both the
cognitive and neurological consequences and examines
the mechanisms of cerebral damage caused by high
temperature.
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Background
An elevated temperature by whatever cause, infective or
non-infective, affects many organ systems of the body,
sometimes with damage which is irreversible, and may
lead to death. A temperature of 37.5 °C or greater at any
point during an admission to the intensive care unit
(ICU) trends towards a worse outcome, and becomes
significant at temperatures greater than 38.5 °C [1].
There is emerging evidence that the central nervous sys-
tem is especially vulnerable to hyperthermia, particularly
if prolonged or excessive. Only in sepsis is there a likeli-
hood that some levels of temperature elevation may af-
ford teleological benefits leading to a survival benefit,
but once the temperature rises above 40 °C it is once
again associated with a worse outcome [1].
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Non-infective causes of hyperthermia include heat ill-
ness and drug-induced hyperthermia. Heatstroke is the
most severe form of heat illness, and is of two forms:
Classical heatstroke (CHS) occurs after exposure to ex-
treme environmental conditions; for example, in heat
waves. Exertional heatstroke (EHS) may occur after
strenuous physical activity, and may be seen in endur-
ance athletes, the military, and others. Hyperthermia is
associated with a number of pharmaceutical agents. Im-
mediate cooling is the mainstay of treatment, with a
delay in a reduction in the temperature associated with
increased mortality [2]. In CHS, cooling to below 38.9 °
C within 60 min is associated with a trend towards im-
proved survival [3]. Further discussion on treatment is
outside the scope of this review and is the subject of a
separate review in this series.
The neurological and cognitive sequelae of elevated
temperature on the brain may be marked during the ini-
tial event and also persist to a much later stage or re-
main permanent despite fever resolution. In this article,
we briefly review the cognitive and neurological effects
of hyperthermia on the brain, and examine some of the
proposed mechanisms by which cerebral damage is
caused.
Clinical patterns
Most patients recover well after a period of hyperther-
mia, but patients exposed to higher temperatures for
longer periods of time are more at risk of complications,
which in extreme cases may progress to multi-organ fail-
ure and death. The risk may be significant; heatstroke,
for example, is associated with a mortality rate of 40 %
[4] to 64 % [2].
Patients who become acutely hyperthermic often dis-
play signs of neurological dysfunction. The neurological
injury may manifest in several ways, including cognitive
dysfunction, agitation, seizures, unsteadiness, or disturb-
ance of consciousness from lethargy to coma. Neuro-
logical dysfunction in heatstroke is well described, and
has been recognised since at least Roman times [5].
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Indeed, the presence of neurological dysfunction is re-
quired for the diagnosis of EHS in combination with
hyperthermia. Cognitive dysfunction also happens quickly
with hyperthermia and may take various forms.
Cognitive dysfunction
Cognition refers to mental abilities and processes, and
includes memory, knowledge, attention, reasoning, prob-
lem solving, and comprehension. The precise anatomical
location of each aspect is not known, and probably in-
volves connections across numerous parts of the brain
[6] including the cerebellum [7].
Hyperthermia, even if mild and only occurring for a
short period, may cause cognitive impairment. In a few
cases, this may be permanent. Hyperthermia has been
shown to adversely affect attention [8], memory [9], and
processing of information [10] acutely. Some of the cogni-
tive processes may be affected by hyperthermia more than
others. Short-term memory processing, for example, may
be more affected than attentional processes [11].
Cognitive impairment may occur after exposure to
more modest temperatures, and after shorter periods of
time, than has previously been recognised. One study of
induced hyperthermia in healthy volunteers showed that
memory was impaired at a core temperature of only
38.8 °C compared with normothermia [12]. Artificially
induced hyperthermia may induce cognitive impairment
after only 1 to 2 h of temperature elevation [10, 13].
Cognitive changes may not occur immediately at the
time of hyperthermic insult, but instead develop a short
time (60–120 min) after the cessation of the insult [13].
Functional neuroimaging supports there being a large
number of pathways and connections in cognitive path-
ways, with many of these being affected acutely in hyper-
thermia. In general, connections appear to be increased
around the limbic system [14], consistent with the ob-
served changes in memory and learning ability. The
dorsolateral prefrontal cortex (involved in executive func-
tions—for example, memory, cognition, and reasoning),
and the intraparietal sulcus (involved in processing and
memory) also show increased activity in acute cerebral
hyperthermia [15]. Conversely, connections in other parts
of the brain, including the temporal, frontal and occipital
lobes, appear to be reduced in acute hyperthermia [14].
Hyperthermia-induced changes in short-term memory
formation can also be detected using electroencephalog-
raphy. The electrical response of the brain to a specific
cognitive or sensory event is termed an ‘event-related
potential’ (ERP). If the brain is subjected to a repeated
identical sound, and then an alternate sound is intro-
duced, the ERP is altered, termed ‘mismatch negativity’
(MMN). MMN has validity in studies into auditory
memory formation. Subjects exposed to hyperthermia
for as little as 1 h show significant decline in MMN
compared with a control group [10], consistent with
clinical observations of a decline in short-term memory.
However, it is not clear whether hyperthermia per se is
causing these acute cognitive changes, or if the heat is af-
fecting changes through or in combination with other
mechanisms. If hyperthermic subjects are kept well hy-
drated, cognitive impairment may be minimal, suggesting
that some of the cognitive dysfunction is due to dehydra-
tion. Body weight loss of 1.0–1.5 kg has been reported in
studies of cognitive change [13], suggesting dehydration,
and it is not clear what effect this has on the cognitive
function.
While advancing age is associated with a reduced cog-
nitive baseline, hyperthermia may not reduce function
proportionately more than in younger people [16]. While
baseline accuracy and ability in attention, memory, and
reaction was lower in older volunteers than younger,
hyperthermia did not alter these reactions differently in
the two groups.
In the majority of cases, patients recover fully from
the acute cognitive dysfunction. Some, however, are left
with persistent changes in attention, memory, or person-
ality [17]. These may be mild, or severe, up to and in-
cluding severe global dementia. They have been reported
after CHS [18], EHS [19], and drug-induced hyperther-
mia [20, 21].
Neurological effects
Neurological manifestations of hyperthermia have been
divided into three groups according to the time sequence
in which they occur: the acute stage, the convalescent
period, and the period of permanent deficits. The magni-
tude and the duration of the hyperthermia are thought to
influence the development of neurological manifestations.
In addition, genotypic and phenotypic differences in the
physiological response to hyperthermia (for example, in
the inflammatory response, or the induction of thermo-
protective mechanisms) may also affect an individual’s risk
of developing neurological deficits.
Acute deficits
Acute neurological deficits have been described after
hyperthermia from a number of causes, including heat
illness and drugs. Deficits are well recognised after
CHS—in the acute phase, many patients have disturb-
ance of consciousness up to and including deep coma.
Of 87 patients with CHS after a Mecca pilgrimage, all
had a reduced level of consciousness, and 25 (29 %) were
deeply comatose [22]. Constricted pupils were reported
in all cases in this series, with 17 (20 %) showing autom-
atisms, including chewing, swallowing, and lip smacking.
Delirium, lethargy, disorientation, seizures, hypertonia,
and hypotonia are also described [23].
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Acute neurological damage after drug-induced hyper-
thermia has been reported to result from malignant
hyperthermia (MH) [24] and neuroleptic malignant syn-
drome (NMS) [20]. Most survivors of NMS recover
completely, with a mean recovery time of 7–11 days
[20]; the incidence of long-term sequelae has been re-
ported at 3.33 % [21].
Persisting deficits
Neurological deficits that persist after the acute phase
are well described. The incidence is difficult to discern;
of 87 patients who developed CHS during the same
Mecca pilgrimage, 75 (87 %) made a full recovery, 10 pa-
tients (11 %) died, and two (3 % of the survivors) recov-
ered but developed pancerebellar syndrome [22]. Of 36
patients with EHS, eight (22 %) died, two (7 % of the
survivors) had cognitive impairment, and a further two
(7 %) had neurological signs, one with paraplegia, and
one with cerebellar disturbance [17].
However, the mortality and morbidity after a severe
episode may be more significant than these data suggest;
if patients require admission to an ICU for management
of hyperthermia, the mortality may approach 50 % to
65 % [2, 25], and persistent neurological effects may
affect 50 % of survivors [25]. Early deaths are usually
from multi-organ failure but, in one study, 50 % of the
deaths were comatose or tetraplegic [2]. In one series of
patients admitted to ICU with CHS after a heatwave,
33 % had significant neurological impairment, and 33 %
of patients had mild impairment at discharge. Only 24 %
of patients had no neurological impairment [23].
Persistent neurological deficits have been reported
after CHS (the majority) and EHS. Cases after drug-
induced hyperthermia are also reported, but are much
rarer. Drugs known to cause hyperthermia and per-
sistent neurological deficits include those responsible
for neuroleptic malignant syndrome [20, 26–29], and
the serotonin syndrome [30], and Chinese herbal
medications [31].
Cerebellar dysfunction is by far the predominant clin-
ical picture in cases of persistent neurological dysfunc-
tion [17, 18, 22, 25, 32–35]. Ataxia, dysarthria, and co-
ordination problems are common; nystagmus is more
rarely reported [32]. Of the five reported cases of persist-
ent neurological dysfunction after NMS, all showed cere-
bellar signs [20, 26–29]. Less common is damage to the
cerebral cortex [34, 36], brain stem [37], spinal cord
[17], and the peripheral nervous system [25]. Frontal
dysfunction is rare, but has been reported. Basal ganglia
dysfunction is reported after heatstroke [34], and is well
recognised after NMS [21, 38]; the latter may represent
the effects of treatment in some patients rather than
damage from hyperthermia. Clinical features are usually
bilateral. Neurological dysfunction may be profound; a
persistent vegetative state has been reported [39]. Pa-
tients may show signs of improvement over weeks or
months [36] but, in some cases, it may persist for many
months or years [18]. Recovery may be minimal or ab-
sent [33]. In the vast majority of these reported cases, a
core body temperature of 40 °C or higher is recorded.
Hyperthermia after brain damage
Fever after brain injury is common, affecting over 70 %
of patients after a traumatic brain injury (TBI) [40] and
in more than 50 % of patients after a subarachnoid
haemorrhage (SAH) [41]. In a proportion, the fever is re-
lated to the neurological injury rather than infection;
non-infective fever may account for up to one third of
cases of fever after a stroke and may affect over a third
of patients after TBI [42]. Development of a fever is as-
sociated with poor outcome; a fever worsens functional
disability and mortality after a stroke [43] and SAH [44].
Adverse effects occur with only small changes in
temperature; variations in the brain temperature of just
1 °C can critically affect the extent of secondary brain in-
jury after a primary insult [43]. Mortality after a stroke
has been shown to increase at temperatures above 37.9 °
C [45], and with a temperature of above 38 °C following
TBI [46].
Radiological and pathological findings
Various radiological findings have been described on
magnetic resonance imaging (MRI) after heatstroke, in-
cluding haemorrhage, oedematous changes, ischaemia,
encephalitis, and atrophic changes [37, 47], suggesting a
number of pathological processes. Lesions have been ob-
served throughout the central nervous system (CNS), in-
cluding the brain stem, cerebellum, hippocampus,
external capsule, and cerebrum [37, 47, 48]. Haemor-
rhage on MRI may represent a poorer prognosis—of
eight patients in one follow-up study, three patients had
evidence of haemorrhage on MRI imaging, and all three
died. The remaining five showed no haemorrhage, and
all survived [47].
Radiological lesions are often bilateral [37, 48], in
keeping with the clinical findings. However, clinical fea-
tures and radiological signs may correlate poorly. Clin-
ical signs may improve and resolve, despite progressive
or non-resolving radiological signs [34]. Radiological
signs may improve despite little clinical improvement
[36], or signs may deteriorate with minimal clinical
change and progression to atrophy may occur [33, 39].
Imaging may show defects in areas of the brain without
clinical deficits [36] or may be normal, despite profound
clinical deficits [32]. Deficits on imaging may develop
late; imaging may be normal on presentation, and abnor-
malities only evident on repeat imaging. MRI is probably
more sensitive than computed tomography.
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Pathological changes are observed on standard T2-
weighted and FLAIR MRI. Diffusion-weighted imaging
(DWI), sensitive for ischaemic changes, and susceptibility-
weighted imaging (SWI), sensitive for haemorrhage, may
be particularly useful in detecting heatstroke-induced
changes [37].
Neuropathological studies of humans with hyperther-
mic damage are rare, but cerebellar damage is frequently
observed, in keeping with the clinical syndrome. In one
reported study of patients with CHS, the Purkinje cells
displayed the most marked thermal damage [49]. Pur-
kinje cells are found predominantly in the cerebellum,
and regulate motor function. Almost complete loss of
the Purkinje cells may be seen when death occurs after
more than 24 h [50]. Neuronal loss may be seen in other
parts of the brain and be replaced by glial cells.
Oedematous and haemorrhagic change is also reported
[50]. In one case series of eight deaths after EHS, reports
of six autopsies showed petechial haemorrhages in a
number of locations in five brains, including the menin-
ges, ventricles, cerebellum, and hypothalamus; an intra-
cranial bleed in two, and venous congestion in three.
Four of the brains had cerebral oedema, and Purkinje
cell degeneration was found in four [17].
NMS may produce similar neuropathological findings;
cerebellar damage may be the most marked, with Purkinje
cell loss and replacement by Bergmann’s glia. Infiltration
by macrophages, and axonal and myelin degeneration also
occurs [26]. In a young patient who died after developing
MH following an appendicectomy, cerebellar damage pre-
dominated, with oedema and herniation [24]. The reason
for this selective thermosensitivity is not clear.
Mechanism of cerebral damage
The mechanism by which cellular and cerebral injury
and death occurs is not yet fully defined, but is probably
multi-factorial. It may be grouped into three broad areas
(Fig. 1); some of these are explored briefly below.
 Cellular effects: membrane, mitochondrial and DNA
damage, stimulation of excitotoxic mechanisms,
protein denaturation
 Local effects: ischaemia, inflammatory changes,
oedema, cytokine release, vascular damage
 Systemic effects: changes in cerebral blood flow,
endotoxaemia, bacterial translocation through a
dysfunctional gastrointestinal tract.
Cellular effects of hyperthermia
Cellular denaturing
Hyperthermia has a number of deleterious effects on
neuronal structure and function, including disruption of
electrochemical depolarisation, trans-membrane ionic
transport and disruption of cellular signalling mecha-
nisms and mitochondrial function [51]. The most
temperature-sensitive cellular elements of neural cells
are mitochondrial and plasma membranes; irreversible
alterations to protein structure appear to occur at tem-
peratures above 40 °C [52]. Protein denaturing may
occur even at normothermia [51], suggesting that repair
mechanisms are sufficient under normal conditions. At
increasing temperatures, the rate of damage increases;
while this process may be reversible, denatured proteins
ultimately form aggregates which disrupt normal cellular
function and prevent replication, and ultimately cell
death. In addition, hyperthermia potentiates neuronal
damage caused by other toxic insults, for example hyp-
oxia and ischaemia [52].
Neuronal death
Thermal stress may result in necrotic cell death, or apop-
tosis, i.e. stimulation of programmed cell death. Cell death,
depending on the cell line, begins to occur at temperatures
Fig. 1 Proposed mechanisms of neuronal damage in hyperthermia
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above 40–41 °C and increases in an exponential manner as
temperature exposure time increases [53]. Apoptosis is
probably more of a risk in rapidly developing cells than in
the adult cerebrum, and may only become a threat at sig-
nificantly elevated temperatures [54]. Protein denaturing is
considered to be the most intimately related factor to cell
death [55], but the precise mechanism varies between cell
types [55]. In some cells, alterations to signalling pathways
are implicated. Caspases are cysteine proteases thought to
be intimately involved in the regulation of apoptosis and
other cellular regulatory processes. Caspase-mediated cell
death may be stimulated by a number of mechanisms; cas-
pase inhibitors appear to prolong neuronal survival after
hyperthermic stress [53].
Cell death, when it occurs, may not be immediate. The
temperature may be high enough to produce cell swell-
ing and necrotic death during or shortly after the heat
stress. More moderate hyperthermia may not produce
such signs immediately, with cell death occurring over
the next few days [51].
Excitotoxicity
Excitotoxicity is the pathological process by which neu-
rones are damaged or killed by excessive exposure to ex-
citatory neurotransmitters—for example, to glutamate
and glycine—which may play a role in damage after a
traumatic brain injury and neurodegenerative disorders
of the CNS, including Alzheimer’s disease and multiple
sclerosis. Increased exposure to excitatory neurotrans-
mitters renders neurones susceptible to calcium influx,
which may reduce ATP production, alter electrochemical
gradients, and stimulate caspase-dependent apoptosis.
After an acute ischaemic stroke, glutamate and glycine
levels are significantly higher in hyperthermic patients
than in normothermia, and the degree of hyperthermia
has further been found to be related to infarct size [56].
Glycine mostly functions as an inhibitory neurotransmit-
ter within the CNS, but is required with glutamate to
co-activate the NMDA receptor.
Protection by heat shock proteins
Heat shock proteins (HSP) are a family of proteins that
are produced by cells in response to exposure to stress-
ful conditions, and are protective against a wide variety
of noxious stimuli, including ischaemia and hyperther-
mia. On exposure of the CNS to hyperthermia, HSP ex-
pression is predominantly in glial and Purkinje cells.
However, as noted above, the Purkinje cells appear to be
the most at risk for damage, and the relationship be-
tween HSP expression and this selective thermosensitiv-
ity is not clear. Many of the sensory and motor neurones
of the CNS show constitutive expression of HSP 27, with
further inducible expression with noxious stimuli. HSP 70
has little or no constitutive expression [57]; expression of
HSP 70 in Purkinje cells may be delayed by several hours,
which may render the cells at risk in the immediate phases.
Other workers suggest that, while HSP confers some pro-
tection, it is also a marker of a cell at risk of damage from
thermal insult [52]. HSPs are expressed in response to the
insult, and their effect may depend on their location: intra-
cellularly located HSPs have a protective role, including
correcting misfolded proteins, preventing protein aggrega-
tion, transport of proteins, and supporting antigen process-
ing and presentation, and limiting apoptosis. In contrast,
membrane-bound or extracellular HSPs may be immunos-
timulatory, and appear to induce cytokine release or pro-
vide recognition sites for natural killer cells; HSPs may have
pro-apoptotic, as well as anti-apoptotic action [58, 59].
Finally, cell death by apoptosis may occur through different
mechanisms, and recent work suggests that HSP may not
provide protection from all these mechanisms [55].
Thermosensitivity of specific cell lines may be ex-
plained by selective expression of other stress-related
proteins. More recent work has isolated heme oxygenase
(HO)-1, the expression of which is predominantly in the
Purkinje cells. Induction of HO-1 aggravates heat shock
injury in cerebellar cells [60].
Changes in cell signalling
Recent work suggests that cellular function is altered by
hyperthermia-induced phosphorylation of members of the
kinase family, critically involved with regulation of cellular
metabolic pathways, in addition to caspase-regulated
apoptosis.
The c-Jun NH2-terminal protein kinase (JNK) plays
important roles in a broad range of physiological pro-
cesses. JNK 2 and JNK 3 are involved in the regulation
of cell differentiation and development, including the in-
duction of apoptosis in response to neuronal stress. Heat
stress alters the function of JNK by alteration in its
phosphylation state [61].
Hyperthermia-induced cognitive dysfunction which
persists may be partly explained by alterations in cell sig-
nalling. Calcium/calmodulin-dependent protein kinase II
(CaMKII) is involved in many signalling cascades and is
thought to be an important mediator of learning and
memory. Exposure to hyperthermia sufficient to cause
seizure in neonatal rats showed significant deficits in
spatial learning and memory. When analysed as adults,
phosphorylation of CaMKIIα Thr(286) was reduced sig-
nificantly, but the phosphorylation of CaMKIIα Thr(305)
was increased significantly, despite the initial thermal in-
sult occurring as neonates [62].
Local effects of hyperthermia
Cytokine induction and the inflammatory response
The expression of a large number of pro- and anti-
inflammatory cytokines changes during the acute and
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recovery phases of a hyperthermic insult. While the pre-
cise expression varies depending upon the cause of the
hyperthermia, the pro-inflammatory cytokines interleu-
kin (IL)-1 and tumour necrosis factor (TNF)-α and the
anti-inflammatory cytokines IL-1RA, IL-10 and soluble
TNF receptors are commonly raised in hyperthermia,
with changes in IL-6 concentration being particularly
related to outcome [63]. Indeed, reduction of the pro-
inflammatory response may be associated with a better
prognosis.
Systemic effects of hyperthermia
Blood–brain barrier disruption and the development of
oedema
The blood–brain barrier (BBB) under normal conditions
is a very selective barrier of tight endothelial cells, pre-
venting the movement of large or hydrophilic molecules,
or toxic substances, into the brain. The permeability of
the BBB is highly temperature-dependent, allowing
significantly increased transport of substances at temper-
atures above 38–39 °C, increasing further at higher tem-
peratures [64]. This increased permeability is considered
by some to be the predominant factor in the develop-
ment of cerebral oedema in hyperthermic states. The
temperature at which cerebral oedema develops corre-
sponds well to that at which disruption to the BBB occurs:
cerebral oedema has been reported in patients dying of
heat-related illness with a core temperature at death of
39 °C [65]. Rats, with a similar core temperature to
humans, develop cerebral oedema and a more permeable
BBB at temperatures above 38.5–39 °C [64].
Cerebral blood flow and metabolism
Cerebral oxygen and glucose consumption generally in-
crease in hyperthermic states, but the precise relationship
with temperature is unclear, and there is considerable re-
gional variability [66]. With modest increases in core
temperature, cerebral metabolic rate increases in some
areas, but decreases in others. In more extremes of hyper-
thermia, mitochondrial oxygen metabolism may not be in-
creased beyond that experienced at normothermia, and
beyond 40 °C may then decrease [66]. This may imply
either impaired uptake of mitochondrial oxygen at hyper-
thermic temperatures, but in the absence of a raised lac-
tate may indicate a reduction in cerebral metabolic
activity at increased temperatures, and thereby account
for the cognitive and neurological signs and symptoms.
Similarly, changes in cerebral blood flow (CBF) are in-
completely understood. Animal studies suggest that CBF
may increase by up to 24 % for every 1 °C increase in
temperature [67], but at temperatures above 40–41 °C
regional CBF may fall to baseline or below [66, 68]. At
temperatures above 40 °C in humans, coupling of cere-
bral flow–pressure becomes deranged. In one study of
patients undergoing therapeutic hyperthermia for hepa-
titis C infection, raising the core temperature to 41.8 °C
was associated with an increase in CBF velocity of 1.5-
to 2-fold, independent of the arterial blood pressure
[69]. This impairment of flow–pressure coupling may
aggravate vascular engorgement and intracranial hyper-
tension, and therefore cerebral oedema [66]. Disruption
of autoregulation may further disrupt BBB integrity, ren-
dering the brain more at risk from systemic insults.
Gut translocation
Systemic hyperthermia increases the permeability of the
gastrointestinal (GI) tract, and increases the rate of gut
bacterial translocation. Blood flow to the GI tract is
reduced, and hyperthermia damages cell membranes, de-
natures proteins, and enhances production of free radi-
cals. The overall result is loss of GI barrier integrity and
the potential for GI-derived endotoxins to enter the in-
ternal environment. Endotoxaemia also initiates the re-
lease of pro-inflammatory cytokines that can produce a
systemic inflammatory cascade and multiple organ dam-
age. Hyperthermia reduces the integrity of the BBB [64],
raising the possibility that some of the neurological
dysfunction is related to GI bacterial or endotoxin trans-
location. In an animal model of heatstroke, antibiotics
improve survival [70].
Heavy metal toxicity
Metals are implicated in a number of neurological clin-
ical syndromes in normothermic conditions. Metal may
be responsible for activation of the free radical-induced
cellular damage in tissues other than the brain in hyper-
thermia [71], and damage to the BBB, for example, by
hyperthermia may exacerbate metal-induced neurotox-
icity. Nanoparticles derived from metals induced brain
dysfunction in normal animals, but under hyperthermic
conditions the cognitive and motor deficits were much
more marked [72].
Conclusions
Hyperthermia is a common insult to the CNS. A variety of
neurocognitive effects are reported, which, in some cases,
may persist after the acute insult. Changes take place at
lower temperatures, following shorter periods of time,
than may have been previously appreciated. In long-term
cases, cerebellar damage predominates, thought to be a re-
sult of the sensitivity of the Purkinje cells to thermal dam-
age. A core temperature of 40 °C or above is associated
with either long-term or permanent neurological damage,
consistent with the cellular changes and cell death occur-
ring above this temperature. Recovery may be minimal;
the mainstay of treatment therefore remains immediate
recognition and cooling to minimise complications.
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A variety of histopathological and neuroradiological
changes are reported after acute hyperthermia; however,
these changes appear to show poor correlation with the
clinical picture overall.
The mechanism of the cerebral damage remains un-
clear, but is likely to be a combination of direct cytotoxic
damage from the hyperthermia and indirect systemic ef-
fects inhibiting neuronal function.
It is not clear which patients are most at risk, but it is
likely that the individual’s physiological response, as well
as the duration of the hyperthermia, may be important.
Further work is needed to clarify how genotypic and
phenotypic differences predispose an individual to devel-
oping neurological deficits. Current treatment is essen-
tially limited to urgent cooling by physical methods;
elucidating the pathogenesis of neurological deficits may
allow development of additional treatment. Of interest is
the role of the inflammatory response, and bacterial and
endotoxin translocation from the GI tract, which may pro-
vide novel targets for future treatments to minimise or
prevent neurological complications after hyperthermia.
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